8




Cancer och Laser

Svenska Laser-Medicinska Sällskapet inbjuder till en cancerdag, fredagen den 18:e maj 2012.

Denna inbjudan vänder sig till dig som forskar eller är intresserade av forskning inom cancerområdet, företrädesvis med användande av ljusmetoder. Här kan du, dels lyssna på presentationer av inbjudna forskare, dela själv presentera forskning.

Den äldsta ljusmetoden, PDT (Photo Dynamic Therapy) daterar sig så långt tillbaka som 1900-talets början men har utvecklats mycket under senare år. Att skära, förånga och koagulera med laser har också utvecklats i och med laser-teknikens framsteg. Andra metoder är laserhypertermi och användning av adjuvanter, där den kanske mest intressanta varianten är inCVAX (in situ cancer vaccine) för behandling av metastaserande tumörer. Vi har bland annat bjudit in Dr Mark Nylor från USA som presenterar: "Laser Immunotherapy for Advanced Melanoma".

Mötet äger rum fredagen den 18:e maj i Stockholm, mellan klockan 09.00 och 18.00. Deltagaravgiften är 1.100 kr (800 kr för medlemmar i SLMS) och inkluderar lunchbuffé, kaffe och viss dokumentation. Deltagare som presenterar forskning deltar för 400 kr. Konferensspråk: engelska.

 

Our invited speaker - Mark Naylor

Short presentation:

Dr. Mark Naylor was a professor of Dermatology at the University of Oklahoma for many years where he was the state expert in cutaneous T-cell lymphoma and melanoma. While at the University of Oklahoma he initiated a number of experimental programs for skin cancer, especially melanoma. In private practice Dr. Naylor has continued his interest in advanced melanoma, and is currently exploring the practical role of laser immunotherapy in clinical medicine.

Medical School
Texas Tech University Health Sciences Center, Lubbock, TX

Internal Medicine Residency
University of Alabama, Birmingham, AL

Dermatology Residency
Texas Tech University Health Sciences Center, Lubbock, TX

Cancer Reserch Fellowship
M.D. Anderson Cancer Center, Science Park o Research Division, Smithville, TX

Current Position
Associate Dermatologist
Dermatology Associates of San Antonio

Title of his presentation:
Laser Immunotherapy for Advanced Melanoma

Mark F. Naylor, Dermatology Associates of San Antonio (USA); Henry Le, Univ. of Central Oklahoma (USA); Hong Liu, The Univ. of Oklahoma (USA); Robert E. Nordquist, Wound Healing of Oklahoma, Inc. (USA); Tomas Hode, Immunophotonics, Inc. (USA); Wei R. Chen, Univ. of Central Oklahoma (USA)

ABSTRACT:
Laser immunotherapy represents a paradigm shift in the treatment of advanced solid tumors. Previously, widely metastatic solid tumors which could not be removed surgically were treated with chemotherapy. Many solid tumors tend to be resistant to chemotherapy, particularly pancreatic carcinoma and melanoma. Laser immunotherapy is a new way to destroy small amounts of residual tumor that cannot be removed surgically. Chemotherapy resistant tumors will be the first diseases in which these techniques will be worked out, due to the conservative approach of most patients who often want whatever method is best understood, even if it is not particularly effective. Although laser immunotherapy will be worked out in tumors resistant to chemotherapy, in practice, it can work for any solid tumor. So far, laser immunotherapy has been applied to advanced breast cancer patients (in which the chemotherapy paradigm has failed) and in melanoma, which is always resistant to traditional chemotherapy. This talk will focus on the theory of laser immunotherapy and our results in melanoma, which in spite of recent advances in FDA-approved drugs for advanced melanoma, remains one of the most difficult to treat solid tumors in medicine.

 

Tillbaka till ingångssidan